Translational Development Acquisition Corp.
Translational Development Acquisition Corp.
Your view on TDACW
Overview
What the company does, where it operates, and who runs it.
About Translational Development Acquisition Corp.
- Industry
- Shell Companies
- Sector
- Financial Services
- CEO
- Michael Hoffman
- Headquarters
- 52 E. 83rd Street, New York City, NY, US
- Industry
- Shell Companies
- Sector
- Financial Services
- CEO
- Michael Hoffman
- Headquarters
- 52 E. 83rd Street, New York City, NY, US
Translational Development Acquisition Corp., established in 2022 and headquartered in New York, New York, currently possesses no significant business operations. Its primary objective is to finalize a strategic business combination, which could involve a merger, share exchange, asset acquisition, or reorganization, with one or more other entities.
Stock Data
Price chart, volume, and trading data.
FRC Fair Value Algorithm
What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.
About this section
Fair value for Translational Development Acquisition Corp. from FRC's valuation model, read against the market price. TDACW last traded at $0.98; the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.
Financial Ratios
Profitability, returns, valuation, and leverage ratios.
About this section
Valuation, profitability, liquidity and leverage ratios for Translational Development Acquisition Corp.. Starting points for Translational Development Acquisition Corp.: EPS -$0.37, beta 2.11 — an Shell Companies name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.
Dividend Analysis
Yield, payout ratio, and dividend coverage metrics.
About this section
Dividend history, yield and payout sustainability for Translational Development Acquisition Corp.. Translational Development Acquisition Corp. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.
Earnings Analysis
EPS history, beat rate, and upcoming earnings reports.
About this section
Reported vs. expected earnings history for Translational Development Acquisition Corp.. Trailing twelve-month EPS for Translational Development Acquisition Corp. stands at -$0.37. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.
Financial Statements
Income statement, balance sheet, and cash flow statements.
About this section
Income statement, balance sheet and cash flow history for Translational Development Acquisition Corp.. Translational Development Acquisition Corp. has reported as a listed company since 2025. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.
Comparables
List of peer companies in the same industry.
More Shell Companies companies
Market cap
- NPACWNew Providence Acquisition Corp. III WarrantsNASDAQ$2M
- NTWONewbury Street II Acquisition CorpNASDAQ$195M
- NTWOUNewbury Street II Acquisition CorpNASDAQ$200M
- NTWOWNewbury Street II Acquisition CorpNASDAQ$187M
- NWAXNew America Acquisition I Corp.NYSE$501M
- NWAX-UNNew America Acquisition I Corp.NYSE$501M
- NXTFFNextraction Energy Corp.OTC$8,492
- OACCOaktree Acquisition Corp. IINASDAQ$263M
- OACCUOaktree Acquisition Corp. III Life Sciences UnitNASDAQ$263M
- OACCWOaktree Acquisition Corp. III Life SciencesNASDAQ$222M
- OBAOxley Bridge Acquisition LimitedNASDAQ$263M
- OBAWUOxley Bridge Acquisition Limited UnitNASDAQ$265M
Insider Trading
Recent buying and selling by company executives.
About this section
Buying and selling by Translational Development Acquisition Corp. executives and directors. Shares of Translational Development Acquisition Corp. have traded between $0.33 and $1.90 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.
News
Latest headlines and market coverage.
About this section
Latest headlines and company announcements for Translational Development Acquisition Corp.. Coverage tracks Translational Development Acquisition Corp. within Shell Companies (Financial Services). Press releases and market coverage, newest first.

Comments
Comments and replies from FRC members about this company.
No comments yet
Be the first to ask a question or say what you make of Translational Development Acquisition Corp.